Echo Health Ventures is a venture capital firm that focuses on investing in health care companies.
Business Model:
Revenue: $0
Employees: 0-0
Address: 1800 9th Ave Ste 250
City: Seattle
State: WA
Zip: 98101
Country: US
Echo Health Ventures is a venture capital firm that focuses on investing in health care companies. From offices in Durham, Portland, and Seattle, Echo Health Ventures invests in health care companies. They work with portfolio companies to accelerate their innovations to scale nationally. As stage-agnostic investors, they are committed to a new approach to strategic investing – an approach that brings more than capital to the table, an approach focused on developing deep, high-value relationships with their portfolio companies.
Contact Phone:
+12062592584
Contact Email:
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
4/2020 | TytoCare | Series D | 0 |
7/2017 | Circulation | Series A | 10.5M |
3/2021 | Scipher Medicine | Series C | 82M |
6/2018 | AccessOne | Private Equity Round | - |
1/2019 | Aledade | Equity | 10M |
2/2022 | Scipher Medicine | Series D | 0 |
5/2019 | DispatchHealth | Series B | 33M |
7/2019 | GNS Healthcare | Series D | 23M |
5/2021 | Eleanor Health | Series B | 0 |
4/2020 | Aledade | Series C | 0 |
9/2022 | Upfront Healthcare Services | Series C | 0 |
5/2020 | Amwell | Series C | 0 |
3/2022 | Embold Health | Series B | 0 |
5/2017 | Upfront Healthcare Services | Series A | 6M |
6/2022 | Abacus Insights | Series C | 0 |
7/2020 | Cityblock Health | Series B | 0 |
4/2023 | Cortica | Series D | 0 |
1/2018 | Springbuk | Series B | 20M |
7/2018 | Octave Bioscience | Series A | 14M |
4/2018 | Livongo | Series E | 0 |
3/2021 | Cityblock Health | Series C | 192M |
5/2021 | Heartbeat Health | Series B | 0 |
3/2021 | Strive Health | Series B | 140M |
11/2022 | DispatchHealth | Series E | 330M |
8/2020 | mPulse Mobile | Series C | 16M |
3/2018 | Wildflower Health | Series C | 8M |
11/2020 | Upfront Healthcare Services | Series B | 0 |
3/2022 | Wildflower Health | Venture Round | 0 |
9/2007 | Phreesia | Series B | 10.3M |
1/2023 | Medix Infusion | Series B | 0 |
8/2021 | Genome Medical | Series C | 0 |
6/2019 | Genome Medical | Series B | 23M |
4/2022 | Waltz Health | Series A | 0 |
12/2020 | Octave Bioscience | Series B | 32M |
5/2019 | Abacus Insights | Series A | 12.7M |
4/2019 | Strive Health | Series A | 80M |
3/2021 | DispatchHealth | Series D | 0 |
7/2021 | Vori Health | Series A | 0 |
7/2020 | Genome Medical | Series B | 0 |
6/2020 | Abacus Insights | Series B | 35M |
1/2022 | mPulse Mobile | Venture Round | - |
5/2018 | mPulse Mobile | Series B | 11M |
4/2019 | Cityblock Health | Series B | 0 |
4/2021 | Ideon | Series B | 23M |
6/2020 | DispatchHealth | Series C | 135.8M |
5/2023 | Strive Health | Series C | 0 |
6/2022 | Abacus Insights | Series C | 0 |
4/2022 | Waltz Health | Series A | 0 |
3/2022 | Embold Health | Series B | 0 |
3/2022 | Wildflower Health | Venture Round | 0 |
2/2022 | Scipher Medicine | Series D | 0 |
1/2022 | mPulse Mobile | Venture Round | - |
8/2021 | Genome Medical | Series C | 0 |
7/2021 | Vori Health | Series A | 0 |
5/2021 | Eleanor Health | Series B | 0 |
5/2021 | Heartbeat Health | Series B | 0 |
Name | Price |
---|
Name | Size | Announced Date |
---|